Steward Partners Investment Advisory’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263 | Hold |
92
| – | – | ﹤0.01% | 4302 |
|
|
2025
Q4 | $297 | Hold |
92
| – | – | ﹤0.01% | 4177 |
|
|
2025
Q3 | $222 | Sell |
92
-1,006
| -92% | -$2.87K | ﹤0.01% | 4169 |
|
|
2025
Q2 | $5.33K | Buy |
1,098
+1,000
| +1,020% | +$3.01K | ﹤0.01% | 3461 |
|
|
2025
Q1 | $144 | Hold |
98
| – | – | ﹤0.01% | 3935 |
|
|
2024
Q4 | $187 | Sell |
98
-64
| -40% | -$142 | ﹤0.01% | 3904 |
|
|
2024
Q3 | $522 | Sell |
162
-29
| -15% | -$104 | ﹤0.01% | 3593 |
|
|
2024
Q2 | $1.33K | Sell |
191
-40
| -17% | -$477 | ﹤0.01% | 3354 |
|
|
2024
Q1 | $4.18K | Buy |
231
+56
| +32% | +$1.12K | ﹤0.01% | 3097 |
|
|
2023
Q4 | $1.85K | Hold |
175
| – | – | ﹤0.01% | 3217 |
|
|
2023
Q3 | $3.45K | Hold |
175
| – | – | ﹤0.01% | 2939 |
|
|
2023
Q2 | $13.4K | Sell |
175
-2
| -1% | -$162 | ﹤0.01% | 2472 |
|
|
2023
Q1 | $16.7K | Sell |
177
-47
| -21% | -$4.47K | ﹤0.01% | 2327 |
|
|
2022
Q4 | $21.8K | Sell |
224
-23
| -9% | -$3.33K | ﹤0.01% | 2202 |
|
|
2022
Q3 | $64K | Buy |
247
+6
| +2% | +$1.74K | ﹤0.01% | 1678 |
|
|
2022
Q2 | $45K | Sell |
241
-63
| -21% | -$6.02K | ﹤0.01% | 1854 |
|
|
2022
Q1 | $30K | Sell |
304
-4
| -1% | -$513 | ﹤0.01% | 2181 |
|
|
2021
Q4 | $50K | Sell |
308
-53
| -15% | -$11.6K | ﹤0.01% | 1914 |
|
|
2021
Q3 | $99K | Buy |
361
+89
| +33% | +$27.2K | ﹤0.01% | 1557 |
|
|
2021
Q2 | $108K | Sell |
272
-27
| -9% | -$12.6K | ﹤0.01% | 2133 |
|
|
2021
Q1 | $161K | Buy |
299
+197
| +193% | +$123K | ﹤0.01% | 1393 |
|
|
2020
Q4 | $38K | Sell |
102
-6
| -6% | -$2.39K | ﹤0.01% | 1802 |
|
|
2020
Q3 | $41K | Hold |
108
| – | – | ﹤0.01% | 1587 |
|
|
2020
Q2 | $53K | Hold |
108
| – | – | ﹤0.01% | 1393 |
|
|
2020
Q1 | $39K | Sell |
108
-41
| -28% | -$21.2K | ﹤0.01% | 1364 |
|
|
2019
Q4 | $105K | Sell |
149
-9
| -6% | -$6.19K | ﹤0.01% | 1122 |
|
|
2019
Q3 | $101K | Sell |
158
-12
| -7% | -$9.52K | ﹤0.01% | 1086 |
|
|
2019
Q2 | $148K | Buy |
170
+42
| +33% | +$28.9K | 0.01% | 909 |
|
|
2019
Q1 | $73K | Buy |
128
+7
| +6% | +$2.93K | ﹤0.01% | 781 |
|
|
2018
Q4 | $34K | Sell |
121
-27
| -18% | -$10.7K | ﹤0.01% | 766 |
|
|
2018
Q3 | $71K | Sell |
148
-17
| -10% | -$7.29K | ﹤0.01% | 1053 |
|
|
2018
Q2 | $75K | Hold |
165
| – | – | ﹤0.01% | 942 |
|
|
2018
Q1 | $96K | Buy |
165
+7
| +4% | +$4.36K | 0.01% | 789 |
|
|
2017
Q4 | $98K | Hold |
158
| – | – | 0.01% | 646 |
|
|
2017
Q3 | $145K | Hold |
158
| – | – | 0.01% | 489 |
|
|
2017
Q2 | $147K | Buy |
158
+3
| +2% | +$2.94K | 0.02% | 451 |
|
|
2017
Q1 | $147K | Hold |
155
| – | – | 0.02% | 373 |
|
|
2016
Q4 | $124K | Buy |
+155
| New | +$140K | 0.06% | 231 |
|
Other funds holding TCRT
VFT
VCM
HF
XT
